Saturday 17 October 2026
Export ALB’s income statement to Excel — free account
Albemarle Corporation
ALB Basic Materials Specialty Chemicals
Albemarle Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, down 4.37% from fiscal 2024. In the quarter to June 2026, revenue grew 31.1%, EPS grew 2,425.0%, free cash flow grew 708.4% and total debt fell 48.2%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.
95.48
2.70
−2.75%
Follow ALB
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(2.31%) | (8.73%) | (5.02%) | 0.69% | |
Piotroski F-Score |
5 | 6 | 6 | 7 | |
| (1.09%) | (4.11%) | (2.49%) | 0.35% | ||
ROIC |
(0.76%) | (2.02%) | (0.88%) | 1.46% | |
Return on Tangible Assets |
(1.60%) | (6.26%) | (3.91%) | 0.55% | |
Average Days of Receivables |
62.07 | 49.58 | 43.81 | 44.96 | |
Free Cash Flow per Share |
1.42 | 6.16 | 5.16 | 11.46 | |
Free Cash Flow |
166.93 | 725.28 | 608.26 | 1,351.43 | |
Capital Expenditures |
(722.47) | (556.99) | (473.04) | (448.89) | |
| Other line items | |||||
Cash ROIC |
1.05% | 4.97% | 4.65% | 9.62% | |
Accounts Receivable Turnover |
5.32 | 6.13 | 7.49 | 7.35 | |
Accounts Payable Turnover |
3.30 | 4.82 | 4.84 | 4.56 | |
Inventory Turnover |
2.72 | 3.34 | 2.98 | 2.98 | |
Average Days of Payables |
118.16 | 74.53 | 76.06 | 90.47 | |
Days of Inventory on Hand |
128.97 | 96.21 | 109.71 | 112.28 | |
Tax Rate |
0.05 | 0.28 | 0.65 | (1.41) | |
Research and Development Expense of Revenue |
1.20% | 1.00% | 0.85% | 0.64% | |
Selling, General and Administrative Expense of Revenue |
10.73% | 10.70% | 10.26% | 9.44% | |
Share Based Compensation of Revenue |
0.72% | 0.78% | 0.75% | 0.64% | |
Interest Coverage |
(0.75) | (1.77) | (0.80) | 1.46 | |
Operating CF/Net income |
(4.73) | (1.89) | (2.71) | 31.35 | |
Depreciation/Fixed assets |
0.09 | 0.10 | 0.10 | 0.10 | |
Capex/Depreciation |
(0.86) | (0.66) | (0.57) | (0.55) | |
Revenue per Share |
42.03 | 43.71 | 46.62 | 50.08 | |
Operating CF per Share |
7.56 | 10.90 | 9.17 | 15.26 | |
Capex per Share |
(6.14) | (4.73) | (4.01) | (3.81) | |
Capex to Sales |
0.15 | 0.11 | 0.09 | 0.08 |
Columns are period end dates